Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ziopharm Oncology IN (ZIOP)

Ziopharm Oncology IN (ZIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ziopharm Oncology IN ONE FIRST AVENUE PARRIS BUILDING 34 BOSTON MA 02129 USA

www.ziopharm.com P: 617-259-1970

Description:

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment.

Key Statistics

Overview:

Market Capitalization, $K 187,118
Shares Outstanding, K 216,146
Annual Sales, $ 0 K
Annual Net Income, $ -79,980 K
Last Quarter Sales, $ 400 K
Last Quarter Net Income, $ -22,730 K
60-Month Beta 1.71
% of Insider Shareholders 5.20%
% of Institutional Shareholders 51.03%
Float, K 204,906
% Float 94.80%

Growth:

1-Year Return -75.61%
3-Year Return -60.29%
5-Year Return -87.27%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 9.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 05/06/21
Next Earnings Date 02/24/22
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -10.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ZIOP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.84%
Return-on-Assets % -72.46%
Profit Margin % 0.00%
Debt/Equity 0.18
Price/Sales 465.47
Price/Cash Flow N/A
Price/Book 2.72
Book Value/Share 0.32
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar